Latest News, Press Releases & Events

Spyryx Biosciences to Present at the 2017 Bio International Convention

DURHAM, N.C., June 16, 2017 - Spyryx Biosciences, Inc., a clinical stage biopharmaceutical company developing innovative therapeutics to address severe lung diseases, today announced that President and Chief Executive Officer, John Taylor, will present a corporate overview at the 2017 BIO International Convention at the San Diego Convention Center in San Diego, California, on Tuesday, [...]
Continue Reading

Spyryx Biosciences Reports Positive Data on SPX-101 at American Thoracic Society International Conference

Preparations Underway for Launch of Multinational Phase 2 Study DURHAM, N.C., May 23, 2017 – Spyryx Biosciences, Inc., a clinical-stage biopharmaceutical company developing innovative therapeutics to address severe lung diseases, shared positive data highlighting clinical safety and pharmacokinetics in healthy volunteers and the preclinical mechanism of action of SPX-101, the Company’s pipeline therapeutic treatment for […]

Continue Reading

Spyryx Biosciences to Present at American Thoracic Society International Conference May 19- 24,2017, Washington, DC

Company to Detail Positive Data for SPX-101 for Cystic Fibrosis DURHAM, N.C., May 16, 2017 /PRNewswire/ — Spyryx Biosciences, Inc., a clinical-stage biopharmaceutical company developing innovative therapeutics to address severe lung diseases, today announced that it will present two abstracts highlighting the safety, pharmacokinetics and mechanism of action of SPX-101, the Company’s pipeline therapeutic treatment […]

Continue Reading